Resvent

What Resvent does

Resvent (融昕医疗) is a Shenzhen-based medical device company founded in 2015 that designs, manufactures, and distributes respiratory care solutions across three segments: critical care ventilation, sleep and respiratory chronic disease management, and digital health. The product portfolio includes high-end invasive ventilators (RS300/RS100, RV200/RV100), the RS200 non-invasive ventilator with integrated HFNC, the iNueview (昕影) chest electrical impedance tomography (EIT) device approved by NMPA in September 2024, the RXiBreeze series CPAP/BiPAP home ventilators, the iApneaMate sleep apnea recorder, the RH100 high-flow therapy unit, and accessories including iRiFiT masks and iTube breathing circuits. Proprietary technology includes the Restrak adaptive synchronization engine, EVAPS/VAPS/APRV ventilation modes, and the ResAssist cloud platform for remote device monitoring. The company holds 670+ patents and trademarks and carries NMPA, CE, FDA EUA, and ISO 13485 certifications.

Resvent operates a hybrid B2B and B2C commercial model. B2B sales target hospitals and ICUs through a direct field sales organization spanning 30+ Chinese provinces with provincial managers, clinical training managers, and field service engineers; the company also participates in government centralized procurement, having won the 2024 Shenzhen bid for non-invasive ventilators. B2C and B2B2C channels include international distributors reaching 200+ countries, a US/Canada subsidiary, and an official overseas online store launched in March 2024. The company reports serving nearly 10 million end users globally and claims the position of the No. 1 Chinese brand in European and US mainstream markets for home-use ventilators. Production is anchored by a 30,000 sqm intelligent manufacturing base in Dongguan opened in February 2024, alongside the Shenzhen headquarters and regional sales offices.

Resvent is privately held, with disclosed funding from a 2017 round involving WI Harper Group and a B+ strategic investment from Cofoe Medical (可孚医疗) in December 2025 intended to combine Cofoe's domestic distribution network with Resvent's international portfolio and certifications. The company has been designated a National Specialized and Novel 'Little Giant' (专精特新小巨人) enterprise and a Guangdong Famous Brand. Winny Yang (杨宁) serves as Chairman of the group.

Name

Resvent

Legal name

深圳融昕医疗科技有限公司

Website

https://resvent.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Resvent (融昕医疗) is a Shenzhen-based medical device company that designs, manufactures, and distributes respiratory care solutions—including ICU ventilators, CPAP/BiPAP devices, EIT imaging, and a cloud monitoring platform—for hospitals, government health systems, and home-use patients across 200+ countries.

Ownership category

akta.pro rank

Product category

Respiratory Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)

akta.pro secondary industries

Sleep Apnea Therapy Devices (CPAP/APAP/BiPAP/ASV) (HLAHAGAA), Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC) (HLAHAGAD), Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters) (HLAHAGAG), Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM), Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF)

Keywords

• Respiratory medical devices
• Ventilators and CPAP
• Sleep therapy equipment
• Chest impedance tomography
• Home medical devices

Headquarters

HQ city

Shenzhen

HQ country

China

HQ region

Asia

Offices7 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

1. Medical Ventilator Sales: Sale of invasive and non-invasive ventilators to hospitals, ICUs, and healthcare institutions. Products include RS200 high-end non-invasive ventilator, RS300/RS100 high-end invasive ventilator, RV200/RV100 portable full-featured ventilator. Primary revenue driver with broad hospital and clinical market penetration.
2. Home-Use Respiratory Device Sales: Sale of home-use ventilators (RXiBreeze, RXiBreeze+, RXiBreeze III), sleep diagnostic equipment (iApneaMate), and accessories (nasal masks, full-face masks, breathing circuits) directly to patients and consumers via retail, distributor, and direct-to-consumer online channels.
3. EIT Device Sales: Sale of iNueview (昕影) Chest Electrical Impedance Tomography device to hospitals for real-time pulmonary monitoring. iNueview received NMPA medical device registration in September 2024, creating a new revenue stream in the critical care segment.
4. ResAssist Cloud Platform Services: Remote device monitoring and data management via ResAssist cloud platform, enabling healthcare providers to track patient device usage and clinical outcomes. Supports both hospital and home-use device ecosystems.
5. Accessories and Consumables: Sale of compatible accessories including iTube breathing circuits (standard and heated), iRiFiT nasal masks, iRiFiT full-face masks, and other consumables for ventilator systems.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

Resvent manufactures and sells respiratory medical devices spanning critical-care invasive and non-invasive ventilators (RS300/RS100, RV200/RV100, RS200) for hospitals and ICUs, home-use CPAP and BiPAP sleep therapy devices (RXiBreeze series) for sleep apnea and COPD patients, the iNueview chest Electrical Impedance Tomography (EIT) imaging device for real-time pulmonary monitoring, and the iApneaMate portable sleep apnea recorder. The company also operates the ResAssist cloud platform for remote device management and patient monitoring, and sells compatible accessories (iRiFiT masks and iTube breathing circuits).

Product overview

Resvent offers a portfolio-based respiratory health solutions business organized across three segments: (1) Critical Care Solutions — including invasive ventilators RS300/RS100 (high-end critical care) and RV200/RV100 (portable multi-function), non-invasive ventilator RS200 (high-end with HFNC integration), and EIT-iNueview昕影 chest electrical impedance tomography device for real-time pulmonary ventilation imaging; (2) Sleep & Respiratory Chronic Disease Solutions — spanning the iApneaMate sleep recorder (diagnostic), RXiBreeze/RXiBreeze+/RXiBreeze III CPAP and BiPAP home ventilator series (treatment), and RXiBreeze bilevel device for COPD; and (3) Digital Health — centered on the ResAssist cloud platform for remote device data management and multi-terminal usage reporting. Supporting the portfolio are iRiFiT mask accessories (full-face and nasal) and iTube breathing circuit tubing (standard and heated). The portfolio covers the full continuum from screening and diagnosis through treatment of sleep apnea and COPD, to ICU-level critical care ventilation.

Differentiator

Problem solved

Functional benefit

Brands

• ResAssist: Cloud-based respiratory health management platform enabling remote patient monitoring, data tracking, and clinical support.
• iNueview / 昕影
• iBreeze / RXiBreeze
• iHope / RS & RV Series
• iApneaMate
• iSyncode / 融畅
• RH100

Products and services

• RS300/RS100 High-end Critical Care Ventilator (RS300/RS100 高端重症治疗呼吸机) High-end critical care invasive ventilator with Restrak adaptive synchronization technology, 18.5-inch HD display, dynamic lung feedback, multiple ventilation modes (including VAPS, APRV), and high-flow oxygen therapy integration. Designed for ICU and critical care departments in hospitals.
• RV200/RV100 Multi-function Ventilator (RV200/RV100 多功能治疗呼吸机) Portable full-function ventilator with 12.1-inch foldable display supporting both invasive and non-invasive modes, single-handle portable design for patient transfer, and rich monitoring parameters including P-V tool and dynamic lung feedback. Targeted at hospitals and patient transport use.
• RS200 High-end Non-invasive Ventilator (RS200 高端无创呼吸机) High-end non-invasive ventilator combining HFNC high-flow oxygen therapy with non-invasive ventilation in one device. Features Restrak adaptive synchronization technology, 18.5-inch HD foldable display, and comprehensive non-invasive ventilation strategies for hospital critical care use.
• iNueview (昕影) Chest Electrical Impedance Tomography (EIT-iNueview 胸阻抗断层成像仪) Self-developed EIT device providing real-time lung ventilation distribution imaging. Supports lung recruitment assessment, PEEP titration, prone position ventilation monitoring, high-flow oxygen therapy evaluation, and ventilator weaning assessment. Sold to hospitals for critical care pulmonary monitoring.
• RXiBreeze III CPAP Therapy Device (RXiBreeze III 正压通气治疗机) Third-generation home-use CPAP sleep apnea treatment device with intelligent algorithms (E-COMP, RAMP, R-Care, iPR), turbo-efficient airflow design for low-noise operation, automatic pressure adjustment, anti-backflow humidification, and auto start-stop. Targeted at home-use sleep apnea patients.
• RXiBreeze+ Auto-adjusting CPAP (RXiBreeze+ 自动调节正压通气治疗机) Portable automatic positive airway pressure (APAP) therapy device weighing 680g, supporting optional humidifier or battery, airplane-compatible. Bluetooth connectivity pairs with oximetry wristband for sleep state monitoring. Targeted at home-use sleep apnea patients.
• RXiBreeze CPAP (RXiBreeze 正压通气治疗机) Full-automatic single-level CPAP device for adult sleep apnea syndrome and sleep quality improvement. Features APAP smart sensing, low-noise operation, built-in humidifier, and remote data management. Targeted at home-use sleep apnea patients.
• RXiBreeze Bilevel PAP (RXiBreeze 双水平正压通气治疗机) Bilevel positive airway pressure therapy device for COPD, pulmonary heart disease, and sleep apnea. Features EVAPS technology, automatic leak compensation, 8-level humidification with no-water dry-burn protection, and cloud-based remote management. Targeted at home-use COPD and respiratory patients.
• iApneaMate Sleep Apnea Recorder (iApneaMate 睡眠呼吸记录仪) First-generation Class III portable sleep apnea monitoring device with Bluetooth wristband pairing, 1.77-inch display, 12-hour continuous recording, 7-lead monitoring, and one-click PDF report generation. For community and primary care sleep screening and diagnosis.
• ResAssist Cloud Platform (ResAssist 呼吸云平台) Cloud-based platform that automatically uploads ventilator and CPAP device usage data to the cloud, accessible via multiple terminals for viewing device usage reports and sleep reports. Enables remote device management and patient monitoring for hospitals, clinicians, and home patients.
• iRiFiT Full-face Positive Pressure Mask Series (iRiFiT 系列正压通气面罩) Full-face positive pressure ventilation mask series with skin-friendly flexible headgear, adaptive V-shaped silicone cushion, and swallowtail exhaust port design for quiet operation. Available in S, M, L sizes. Sold as a standalone accessory for ventilator users.
• iRiFiT Nasal Mask Series (iRiFiT 系列正压通气鼻罩) Nasal mask series with swallowtail exhaust port design for quiet operation. Available in N300-M and N300-L sizes. Sold as a standalone accessory for ventilator users.
• iTube Breathing Circuit Tubing (iTube 系列呼吸管路) Breathing circuit tubing available in 15mm and 19mm sizes with premium materials and anti-pressure anti-kink structure. Also includes 19mm heated breathing circuit with integrated heating wire for temperature-controlled gas delivery. Sold as a standalone consumable accessory for ventilator systems.

Quantifiable outcome

• Real-time lung ventilation distribution visualization reducing time to personalized treatment strategy
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Omron (欧姆龙)coreStrategic or Co-development PartnerResvent partnered with Omron to co-develop and launch home single-level ventilator (CPAP) products. The iBreeze+ series home-use ventilator was developed in collaboration with Omron, combining Resvent's respiratory device expertise with Omron's technology and market presence.
• Shenzhen Respiratory Disease Research Institute (深圳市呼吸疾病研究所)minorStrategic or Co-development PartnerResvent participated in the 8th National Sleep Respiratory Diseases Academic Conference co-organized by the Chinese Medical Association. The company collaborates with academic medical institutions for clinical research and product validation in sleep and respiratory medicine.

Scale indicators12 records

Recent moves11 records

Expansion highlights8 records

Direct peers

• Apex Medical: Taiwan-based manufacturer specializing in sleep apnea and respiratory care products, including CPAP/BiPAP devices, hospital ventilators, and patient interfaces. Direct competitor in Asian, European, and emerging market channels with similar mid-market positioning to Resvent.
• Dräger: German medical and safety technology company with a major anesthesia and ventilation business, competing in ICU ventilators and patient monitoring. Direct competitor to Resvent's high-end invasive ventilator line in hospital procurement globally.
• Hamilton Medical: Switzerland-based specialist in high-end ICU mechanical ventilators and intelligent ventilation technologies. Directly competes with Resvent's RS300/RS100 high-end critical care ventilators in the premium hospital segment globally.
• ResMed: Global leader in sleep apnea and CPAP/BiPAP therapy devices, cloud-connected platforms (myAir), and home respiratory care. Directly competes with Resvent's RXiBreeze home-use sleep therapy line in both European and US markets, with much larger installed base and brand equity.
• BMC Medical: China-based competitor in respiratory care devices, particularly CPAP/BiPAP and sleep diagnostic products. Closest direct Chinese peer to Resvent, competing in both domestic hospital procurement and international home-use ventilator markets.
• Philips Respironics: Major global competitor in hospital and home-use ventilators, CPAP/BiPAP devices, and sleep diagnostics. Direct overlap with Resvent's invasive and non-invasive ventilator lines as well as sleep therapy portfolio. Currently navigating CPAP device recall issues which may create share-shift opportunities for Resvent.
• Löwenstein Medical: German family-owned medical technology company focused on sleep medicine, ventilation, and anesthesia. Direct competitor in European hospital ventilation and home sleep therapy markets, with strong KOL relationships and clinical evidence base.

Broad incumbents

• Mindray: One of China's largest medical device manufacturers with a broad portfolio including patient monitoring, IVD, and increasingly medical imaging. Their ventilator and patient monitoring lines compete with Resvent in Chinese hospital procurement, with much greater scale and a public-company capital base.
• Yuwell (鱼跃医疗): Major Chinese home medical device company with broad portfolio including blood pressure monitors, oxygen concentrators, nebulizers, and respiratory products. Listed peer competitor in the Chinese home-use respiratory and DME market, and a logical comparison point for Resvent's consumer-facing growth strategy.

Emerging players

• Microlife: Swiss-based home medical device company with focus on blood pressure monitoring, respiratory care (nebulizers, peak flow meters), and emerging sleep apnea diagnostics. Partial overlap with Resvent's home-use respiratory portfolio, particularly in consumer and pharmacy channels outside the US.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries4 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Resvent